Stem Cell Research
New Findings Reported from First Affiliated Hospital Describe Advances in Stem Cell Research
Published in Cancer Weekly, March 27th, 2012
2012 MAR 27 -- A new study, "Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells," is now available. "MiR-21 is known to play an important role in the development and progression, including migration and invasion, of many malignancies including breast cancer. Accumulating evidence suggest that the induction of epithelial-mesenchymal transition (EMT) phenotype and acquisition of cancer stem cell (CSC) characteristics are highly interrelated, and contribute to tumorigenesis, tumor progression, metastasis, and relapse," researchers in Chongqing, People's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2012-03-27)
More Articles from Cancer Weekly
- Colon Cancer
Cigna Campaign Encourages 600,000 Customers to Get Colorectal Cancer Screening - Lung Cancer
Data on Lung Cancer Discussed by Researchers at University of Iowa - Lung Cancer
Data on Lung Cancer Published by M.C. Chang and Colleagues - Pelvic Cancer
Data on Pelvic Cancer Described by Researchers at Seoul National University - Seroma
Data on Seroma Described by Researchers at University of Southern Florida - Prostate Cancer
Findings from George Washington University in Prostate Cancer Reported - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
